PMC7747096_01
Timeline of treatment sequence, with response and predominant adverse effect.
10.1177_1178223420976387-fig1.jpg
PMC7747096_01_10.1177_1178223420976387-fig1.jpg
fig1-1178223420976387
Figure 1 shows the timeline of different treatments that the patient received along with the adverse effects experienced and disease response.
Next-generation whole-exome sequencing of lymph node biopsy sample revealing the presence of de novo mutation in ERBB2, RET, and BRCA1 copy number loss along with high tumor mutational burden (TMB).
10.1177_1178223420976387-fig2.jpg
PMC7747096_01_10.1177_1178223420976387-fig2.jpg
fig2-1178223420976387
Figure 2 shows the detailed results of the next-generation whole-exome sequencing report for our patient.